Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.70 is 59% above its 5-year average of -4.12, near the high end of its 5-year range (-9.04–-1.59).
4.94% below its 12-month average of -1.62.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.33.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.70
EARNINGS PER SHARE (EPS) AVG TTM
-1.62
EARNINGS PER SHARE (EPS) AVG 3Y
-2.84
EARNINGS PER SHARE (EPS) AVG 5Y
-4.12
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.94%
CURRENT VS 3Y AVG
+40.09%
CURRENT VS 5Y AVG
+58.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
electroCore, Inc.
Market Cap
$90.38M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.62
3Y Avg
-2.84
5Y Avg
-4.12
Market Cap
$90.47M
Earnings Per Share (EPS)
0.08
TTM Avg
-0.19
3Y Avg
-0.36
5Y Avg
-0.27
Market Cap
$90.85M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.31
3Y Avg
-0.33
5Y Avg
-0.76
Market Cap
$89.70M
Earnings Per Share (EPS)
-1.23
TTM Avg
-1.49
3Y Avg
-1.33
5Y Avg
-1.26
Market Cap
$89.38M
Earnings Per Share (EPS)
7.80
TTM Avg
-6.12
3Y Avg
-10.92
5Y Avg
-10.81
Market Cap
$89.33M
Earnings Per Share (EPS)
-1.42
TTM Avg
-1.31
3Y Avg
-1.42
5Y Avg
-1.39
Market Cap
$92.92M
Earnings Per Share (EPS)
-0.50
TTM Avg
-2.50
3Y Avg
-2.81
5Y Avg
-2.25
Market Cap
$86.90M
Earnings Per Share (EPS)
0.07
TTM Avg
-0.09
3Y Avg
-1.24
5Y Avg
-1.25
Market Cap
$94.27M
Earnings Per Share (EPS)
-0.91
TTM Avg
0.49
3Y Avg
1.23
5Y Avg
1.23
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| electroCore, Inc. (ECOR) | $90.38M | -1.70 | -1.62 | -2.84 | -4.12 |
| ImmuCell Corporation (ICCC)vs › | $90.47M | 0.08 | -0.19 | -0.36 | -0.27 |
| Equillium, Inc. (EQ)vs › | $90.85M | -0.26 | -0.31 | -0.33 | -0.76 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.70M | -1.23 | -1.49 | -1.33 | -1.26 |
| Rallybio Corporation (RLYB)vs › | $89.38M | 7.80 | -6.12 | -10.92 | -10.81 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | -1.42 | -1.31 | -1.42 | -1.39 |
| Biomea Fusion, Inc. (BMEA)vs › | $92.92M | -0.50 | -2.50 | -2.81 | -2.25 |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 0.07 | -0.09 | -1.24 | -1.25 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $94.27M | -0.91 | 0.49 | 1.23 | 1.23 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.36M | -1.18 | -4.40 | -32.48 | -54.06 |
Trailing EPS (TTM)
$-1.70
Forward EPS (Est.)
$-1.38
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.65 |
| 2024-12-31 | -1.59 |
| 2023-12-31 | -3.42 |
| 2022-12-31 | -4.69 |
| 2021-12-31 | -4.36 |
| 2020-12-31 | -9.04 |
| 2019-12-31 | -23.05 |
| 2018-12-31 | -28.61 |
| 2017-12-31 | -5.52 |
| 2016-12-31 | -1.57 |
